United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Life Science Sector Plans Issued

We've recently written about the UK's industrial strategy and its specific plans for the tech and creative sectors. It has now published its life sciences sector plan - and so has the EU...

United Kingdom Healthcare

LS

Lewis Silkin

A New European Strategy To Foster Life Sciences Innovation And Market Access

On July 2, 2025, the European Commission released its communication "Choose Europe for life sciences. A strategy to position the EU as the world's most attractive place...

European Union Healthcare

AO

A&O Shearman

Tackling The Source Of Phantom Limb Pain With Nerve Stimulation

Millions of people worldwide suffer from pain that is perceived to be in an area of the body that is paradoxically no longer (or never was) attached to the body.

United Kingdom IP

MC

Marks & Clerk

The Case For Core Focus Among Mid-market Medical Device Companies

Mid-market medical device companies are grappling with underperformance, driven in part by over-diversified portfolios and fragmented management focus.

United Kingdom Healthcare

A

AlixPartners

Neurotech Patents In Europe: Part 2 - Novelty, Inventive Step, And Device-Specific Pitfalls

United Kingdom IP

MC

Marks & Clerk

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

Worldwide Healthcare

PC

Potter Clarkson

The Pioneers: Financial Times Interview With Michelle Mitchell

United Kingdom Healthcare

WL

Withers LLP

Supporting Growth – What Does The UK's Industrial Strategy Mean For Life Sciences?

United Kingdom Healthcare

GW

Gowling WLG

UK Government Issues New Industrial Strategy

United Kingdom Strategy

LS

Lewis Silkin

EU Medical Device Software: New Guidance On Placing Software Medical Devices On The EU Market

European Union Healthcare

AP

Arnold & Porter

Personalised Medicine And MedTech

United Kingdom Healthcare

LS

Lewis Silkin

UPC Delivers First Judgment On Validity And Infringement Of A Second Medical Use Claim

United Kingdom IP

HL

HGF Ltd

Looking To The Future - UK Biotech In 2035

The bioindustry association (BIA) have issued a new report setting out their vision for UK biotech in 2035. The headline approach is that there needs to be a "shift in mindset" to unlock the UK's full potential.

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies.

European Union Healthcare

AP

Arnold & Porter

£13.9bn Of R&D Funding

The UK government has announced a record-breaking £13.9 billion in research and development (R&D) funding for the coming year.

United Kingdom Strategy

IG

IR Global

The Effect Of The Unified Patent Court (UPC) On Opposition Proceedings At The European Patent Office (EPO)

The introduction of the Unified Patent Court (UPC) has brought significant changes to the European patent landscape.

United Kingdom IP

KL

Keltie LLP

Global Insights: Patent Protection For Polymorphs

B

Boult Wade Tennant

Recent Updates On Reform Of UK Clinical Trial Landscape

United Kingdom Healthcare

AP

Arnold & Porter

Blueprints For Growth: Perspectives On Life Sciences & Innovation Investments

United Kingdom Real Estate

AG

Addleshaw Goddard

Future R&D Funding In The UK

United Kingdom Healthcare

MC

Marks & Clerk

Going Down The Bio-Produced Silk Road

United Kingdom IP

MC

Marks & Clerk

A New Approach To Regulation By The MHRA And NICE

United Kingdom Healthcare

AO

A&O Shearman

ABPI Calls For Changes To "Unsustainable" Medicines Pricing Scheme

United Kingdom Healthcare

AP

Arnold & Porter

Is Seaweed The New Wonder Product?

United Kingdom Healthcare

MC

Marks & Clerk

Will Labour's Policy Prescription Create A Stronger UK Life Sciences Sector?

United Kingdom Healthcare

AO

A&O Shearman

What To Know When Selling Your Pharmacy

United Kingdom Healthcare

RF

Ronald Fletcher Baker

ABPI Calls For Changes To "Unsustainable" Medicines Pricing Scheme

The Association of the British Pharmaceutical Industry (ABPI) has published a report (the Report) setting out its members' concerns regarding...

United Kingdom Healthcare

AP

Arnold & Porter

Is Seaweed The New Wonder Product?

We have previously reported (here and here) on some of the innovative and diverse uses seaweed is being put to. I was therefore intrigued to read an article in the Guardian newspaper...

United Kingdom Healthcare

MC

Marks & Clerk

Will Labour's Policy Prescription Create A Stronger UK Life Sciences Sector?

The UK government plans to turbocharge the life sciences sector using policy levers to enhance research and development, innovation hubs, and private fundraising.

United Kingdom Healthcare

AO

A&O Shearman

What To Know When Selling Your Pharmacy

Selling a pharmacy is never easy—especially when you've spent years building it, earning a strong reputation in the local community, and serving patients with dedication.

United Kingdom Healthcare

RF

Ronald Fletcher Baker

EU Leads Global Charge As Abuse Of Dominance Cases Target Big Tech

Worldwide Anti-trust

AO

A&O Shearman

Multidrug-Resistant Bacteria Discovered In Space

Microbes are ubiquitous here on Earth and can survive a range of environmental conditions encompassing broad ranges of temperature, pH, salinity, energy, and nutrient levels.

United Kingdom Healthcare

B

Boult Wade Tennant

X-Traordinary Ageing: Silent X Chromosome Awakens To Boost Female Brain

As someone with a genetics background I can think of no better way to celebrate International Women's Day than with a paper on the power of the X chromosome. We were always taught that in XX individuals one X...

United Kingdom Healthcare

MC

Marks & Clerk

Patentability Of AI Inventions In Europe: Life Sciences, Chemical And Biotechnology Inventions

Whilst there may still be hurdles to overcome, and despite some misconceptions, AI inventions can be patented in Europe and have found particular application...

European Union IP

M

Murgitroyd

Online Pharmacies Required To Strengthen Safeguards To Prevent Unsafe Supply Of Medicines In The UK

The UK's General Pharmaceutical Council (GPhC) has published new guidance for registered pharmacies providing pharmacy services at a distance, including on the internet.

United Kingdom Healthcare

AP

Arnold & Porter

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

How Will The Trump Administration Affect The UK Biotech Industry?

United Kingdom Healthcare

MC

Marks & Clerk

Proprietary Association Of Great Britain (PAGB) Updated Professional Code For Medicines

United Kingdom Healthcare

AP

Arnold & Porter

A Snapshot Into HLK's 175-year History

United Kingdom IP

H

HLK

EU Biosimilar Regulatory And Launch Updates

European Union Healthcare

GP

Goodwin Procter LLP

AI, Multi-Omics And Digital Health Technologies Driving 2025 Biopharma And Life Sciences Pay Trends

Worldwide Healthcare

W

WTW

UPC Court Of Appeal Confirms Strict Approach To Correcting Patent Errors By Interpretation

European Union IP

AO

A&O Shearman

Trends, Challenges And Opportunities Shaping The Future Of Rewards In The Life Sciences Industry

United Kingdom Healthcare

W

WTW

Dr Michelle Pratt In Conversation With Dr Nina White

United Kingdom Healthcare

B

Boult Wade Tennant

New Year Update: Incoming Changes To UK Regulation Of Clinical Trials

United Kingdom Healthcare

AP

Arnold & Porter

MHRA Launches The 2025 Pilot Real-World Evidence Dialogue Programme – Implementing Broader Data Strategy And Pro-Innovation Regulatory Framework

United Kingdom Healthcare

RG

Ropes & Gray LLP

Life Sciences – Trends And Predictions For 2025

United Kingdom Healthcare

LS

Lewis Silkin

AI And Life Sciences – A Practical Guide To Protecting Your Innovations

United Kingdom IP

LS

Lewis Silkin

Don't Be Afraid To Burn The Midnight Oil: Additive Manufacturing And MedTech

European Union IP

MC

Marks & Clerk

New Year, New UK-Wide Licensing Regime

United Kingdom Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

EU And UK Compliance Considerations In Remote Promotion Training And Medical Information Services (Video)

AP

Arnold & Porter

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

The International Advantage Of Using A UK Patent Attorney - Dehns And ConceptoMed

D

Dehns

Measuring The Return From Pharmaceutical Innovation 2012 (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More